Skip to main content

Table 1 Characteristics of the study population

From: Prescription of lipid-lowering medications for patients with type 2 diabetes mellitus and risk-associated LDL cholesterol: a nationwide study of guideline adherence from the Swedish National Diabetes Register

Characteristics

Primary prevention

n = 756,953

Secondary prevention

n = 447,423

Men, n (%)

396,028 (52.3)

274,891 (61.4)

Age, mean

63.7 ± 11.7

71.5 ± 9.5

Diabetes duration, mean years

7.4 ± 7.1

10.5 ± 8.4

HbA1c, mean mmol/mol

54.7 ± 14.6

55.5 ± 13.7

Diabetes medications, n (%)

560,539 (74.4)

350,387 (78.5)

Antiplateletsa, n (%)

171,114 (23.1)

316,290 (72.1)

Antihypertensives, n (%)

508,907 (68.6)

401,935 (90.9)

Systolic blood pressure, mean mmHg

137.2 ± 16.4

136.2 ± 16.9

Diastolic blood pressure, mean mmHg

78.5 ± 9.6

74.9 ± 9.8

Total cholesterol, mean mmol/l

5.4 ± 0.9

4.7 ± 1.0

LDL cholesterol, mean mmol/l

3.4 ± 0.7

2.7 ± 0.8

HDL cholesterol, mean mmol/l

1.3 ± 0.4

1.2 ± 0.3

Triglycerides, mean mmol/l

1.8 ± 0.9

1.8 ± 0.9

eGFR, mean ml/min/1.73 m²

85.6 ± 25.1

74.3 ± 25.0

Microalbuminuria, n (%)

92,812 (17.8)

77,698 (25.6)

Macroalbuminuria, n (%)

29,895 (5.7)

35,005 (11.3)

BMI, mean kg/m2

30.1 ± 5.4

29.7 ± 5.1

Physical activity < once a weekb, n (%)

105,300 (24.2)

87,486 (32.8)

Smokingc, n (%)

103,874 (17.1)

49,766 (13.7)

  1. Abbreviations: HbA1c, haemoglobin A1c; LDL, low-density lipoprotein; HDL, high-density lipoprotein; eGFR, estimated glomerular filtration rate; BMI, body mass index
  2. aATC code B01AC and N02BA01
  3. b30-minute walk or equivalent
  4. csmoking at least one cigarette or pipe per day, or quit smoking within three months